Latest news with #QatarFoundationforEducation
Qatar Tribune
6 hours ago
- General
- Qatar Tribune
Qatar Foundation launches Islamic Civilisation curriculum in its schools starting with new academic year
DOHA: Qatar Foundation for Education, Science and Community Development (QF) has announced the inclusion of the 'Islamic Civilisation' curriculum in its educational curriculum starting from the 2025-2026 academic year. This comes as part of its efforts to strengthen students' connection to their cultural roots and consolidate their understanding of their national and cultural identity. The Foundation explained in a statement that the new curriculum is an innovative educational course aimed at students in grades six through nine in schools affiliated with Qatar Foundation's Pre-University Education. It explores the most important milestones of Islamic civilisation across four pivotal eras, through interactive educational tracks that connect values, knowledge, and identity, working to instill a sense of belonging and enhance historical awareness. In this context, Sarah Al Hajri, Director of Student Affairs and Community Partnerships at Pre-University Education at Qatar Foundation, said: 'This course addresses the existing gap in international school curricula, where students study Qatari history without a comprehensive understanding of the history of Islamic civilization in its comprehensive sense.' She added that the curriculum enables students to learn about the contributions of Islamic civilisation to the human journey, linking the past to the present, and the general to the specific, thus shaping a balanced awareness that enhances self-esteem and guides a sense of belonging. She explained that the curriculum is distinguished by its focus on analysing the impact of Islamic civilisation on various aspects of life and the contributions it has made to humanity, departing from the traditional narrative of historical events. She pointed out that the curriculum's implementation relies on inquiry-based research units, whereby students receive basic information, explore its developments and applications, and connect it to contemporary reality. She emphasized that this represents an investment in students' awareness and a stimulating educational experience that unleashes their energies for the future. For his part, Dr Ali Al Sallabi, Secretary-General of the International Union of Muslim Scholars and one of the participants in the curriculum review, emphasized that the inclusion of Islamic Civilisationin school curricula represents a crucial step in light of the intellectual and cultural challenges facing the new generation. An Islamic writer and preacher specializing in Islamic history, thought, and Quranic interpretation, he explained that the past decades have witnessed the dominance of cultural movements in the Arab and Islamic world, influencing its intellectual and civilisational dimensions. He noted that the influence of these movements persists despite their declining military and political presence. He said that Islamic civilisation is characterized by material, moral, spiritual, and moral dimensions that the new generation needs more than ever before. Teaching this civilisation contributes to saving generations from confusion and providing them with a compass that guides them and a light that directs them to the Book of God and the Sunnah of His Prophet. He pointed out that the curriculum review focused on including prominent cultural landmarks, inspiring stories, Quranic verses and Prophetic hadiths, as well as highlighting influential figures in the nation's history, and arranging the content to reflect the manifestations of Islamic civilisation. Dr Al Sallabi concluded by saying: "The new curriculum enhances students' understanding of the achievements of Islamic civilisation and its role in the contemporary world. It also empowers teachers to play a key role in broadening students' horizons and encouraging dialogue and discussion in a manner that combines logic and emotion, deepening their pride in their religion and history and motivating them to learn more about their ancient civilisation."
Qatar Tribune
06-07-2025
- Business
- Qatar Tribune
Seventh edition of 'My Career - My Future' programme kicks off with participation of over 250 students
DOHA: The seventh edition of the 'My Career - My Future' job shadowing programme has kicked off. The programme, organised by the Qatar Career Development Center (QCDC), part of Qatar Foundation for Education, Science and Community Development (QF), is being held with the participation of more than 250 high school students from various schools across the country, distributed among 25 entities from the public and private sectors. During the opening ceremony at the Education City Student Center Forum building, high school students and representatives of participating entities were briefed on the program's agenda and activities and listened to a detailed explanation from the entities' representatives, preparing them for the experience of experiencing the work environment. In his opening remarks, Saad Abdullah Al Kharji, Executive Director of the Qatar Career Development Center, emphasized that the program has continued to achieve success since its launch seven years ago. He said, "Seven years have passed, and this program continues to flourish year after year, just as the aspirations of our youth flourish, and our hopes for them and with them grow." He added: "We meet today to open a window to the future through which our youth can see their professional ambitions in action. Just one week is enough to open eyes to the reality of work and instill confidence in people. We have seen its impact in previous editions in the eyes of students returning from training with more mature personalities and clearer ambitions." The Executive Director of the Qatar Career Development Center concluded his remarks by saying, "At the Center, we believe that true investment is investment in people. We strive to empower our youth to choose their own paths, after providing them with the tools and experiences that will help them make informed decisions." The programme aims to provide secondary school students in grades 10, 11, and 12 with the opportunity to experience real-life work environments and interact directly with experienced professionals. This will enhance their awareness of the nature of various professions and help them make informed academic and professional decisions that align with their ambitions and abilities. Over the coming days, students will undergo field experiences in a number of vital sectors in the country, including medicine, aviation, energy, media, communications, finance, business administration, judiciary, tourism, sports management, technology, engineering, communications, humanitarian and social work, and other disciplines related to the country's sustainable development paths.
Qatar Tribune
01-07-2025
- Entertainment
- Qatar Tribune
Sheikha Moza visits VCUarts Qatar exhibition
DOHA: Chairperson of Qatar Foundation for Education, Science and Community Development HH Sheikha Moza bint Nasser has visited the annual 'Art and Design Now: Year End Show' presented by the Class of 2025 students and graduates of Virginia Commonwealth University School of the Arts in Qatar. In a post on her X account, Sheikha Moza said, "I was delighted to visit the annual Art and Design Now: Year End Show at M7, presented by the talented Class of 2025 students and graduates of @VCUQatar . The exhibition showcases innovative and creative works by more than 70 emerging artists and designers. These inspiring projects reflect a deep connection to culture, technology, and contemporary issues, offering a glimpse into the promising future of art and design in Qatar. The Art and Design Now: Year End Show presents a dynamic vision of the future of art and design, addressing themes such as cultural identity, environmental sustainability, and social awareness. The exhibiton will continue till July 5.
Qatar Tribune
03-06-2025
- General
- Qatar Tribune
Sheikha Moza opens HSCT ward at Sidra Medicine
Tribune News Network Doha HH Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development, officially inaugurated the new paediatric Hematopoietic Stem Cell Transplant (HSCT) ward at Sidra Medicine, a Qatar Foundation entity. The new ward is dedicated to treating children with blood disorders, immune system diseases, and genetic conditions. During the visit, Sheikha Mozatoured the facility, engaged with clinical teams, and received an overview of the HSCT programme's role in advancing care and stem cell and gene therapies for children in Qatar and the region. Sheikha Moza was accompanied by Minister of Public Health HE Mansoor bin Ebrahim bin Saad Al Mahmoud, members of Sidra Medicine's Board of Directors and senior leadership, including Dr Iyabo Tinubu-Karch, Chief Executive Officer and Prof Ibrahim Janahi, Chief Medical Officer. The HSCT ward is a core part of Sidra Medicine's HSCT Programme, using curative therapies to provide life-saving care and treatment for children with a range of blood diseases and cancers. This includes malignant and non-malignant conditions such as leukemia, lymphoma, thalassemia, sickle cell disease, immune deficiencies, and metabolic disorders. HSCT also known as bone marrow transplant, replaces diseased or damaged bone marrow with healthy stem cells from the patient (autologous) or a donor (allogeneic). Dr Iyabo Tinubu-Karch, CEO of Sidra Medicine, said: 'The opening of our new pediatric Hematopoietic Stem Cell Transplant Ward, the first of its kind in the country, marks a major step in expanding access to life-saving care for children in Qatar and the region. As the HSCT program grows, it will play a vital role in reducing the need for outbound referrals and in positioning Qatar as a center of excellence for pediatric cell and gene therapies. This is about building sustainable, high-quality care close to home for our patients and their families.' Prof. Ibrahim Janahi, Chief Medical Officer at Sidra Medicine, said: 'The launch of the HSCT Ward reflects our commitment to supporting the Qatar National Vision 2030. It strengthens the foundation of a knowledge-based economy by building national expertise in precision and regenerative medicine. Our goal is to ensure that every child in Qatar can access the best possible treatment, close to home and grounded in clinical excellence.' Managed by the Hematology and Oncology Division at Sidra Medicine, the new ward is designed exclusively for pediatric patients under the age of 18. It is divided into two main sections - one section for children undergoing HSCT and the other for patients with complex hematology-oncology diagnoses such as cancer, that require intensive chemotherapy and inpatient care. With an initial capacity of 20 beds, the new pediatric HSCT ward integrates cutting-edge infrastructure, including high-level isolation facilities that meet international infection control standards. It is scheduled to receive patients for autologous transplants in late June of 2025 with preparations underway to care for inpatient children who will undergo allogeneic transplants, at a later stage. Dr Ayman Saleh, Division Chief of Pediatric Hematology-Oncology & Hematopoietic Stem Cell Transplant at Sidra Medicine said: 'Our HSCT program brings together key specialties to deliver advanced and curative care for children with complex conditions. With four autologous procedures successfully completed and plans underway to offer allogeneic transplants in the near future, we are building a strong foundation for pediatric cellular therapy in Qatar. This service is a testament to the pioneering and family-centered care and cure approach that we offer to all our patients.' In addition to treating patients with various blood diseases and cancers, the HSCT program at Sidra Medicine is the core part of its precision medicine strategy to facilitate genomic research programs for pediatric autoimmune disorders, genetic and rare diseases. Sidra Medicine's HSCT program is further enhanced by a Good Manufacturing Practice (GMP)-qualified laboratory team operating under the Advanced Cell Therapy Core (ACTC). The ACTC manages the processing and cryopreservation of hematopoietic stem cells and is currently working toward Sidra Medicine's qualification as a treatment center for Casgevy, a gene therapy for thalassemia and sickle cell disease. Dr Chiara Cugno, Director of the Advanced Cell Therapy Core and GMP Facility at Sidra Medicine said: 'Our GMP-qualified laboratory is a key enabler in delivering safe and effective cellular therapies. By maintaining the highest standards in cell processing and cryopreservation, we are supporting precision treatments for children with cancer, blood, and immunologic disorders. It is an essential part of ensuring every child receives the most personalized care possible.' All HSCT program services will be open to both local and international patients, with more than 50 children currently awaiting transplantation in Qatar. Future phases for the HSCT program include scaling allogeneic transplant capacity and introducing CAR-T cell and gene therapies. The HSCT program includes a multidisciplinary team of specialized physicians, apheresis-trained staff, dedicated HSCT nurses, and allied health professionals. The Sidra Medicine care team also involves experts in immunology, infectious diseases, radiology, psychology, pharmacy, nutrition, child life, and social work. The integrated approach ensures comprehensive and patient-centered care throughout the transplant journey. Before a transplant, every child will go through a detailed evaluation at Sidra Medicine's outpatient clinic to ensure they are ready for the procedure. Once admitted, the children will undergo conditioning chemotherapy to prepare their bodies for the stem cell infusion. They will then be monitored very closely during the aplasia phase, when their immune system is at its weakest. Most patients will stay at the hospital for about 30 to 40 days. Following discharge, they will continue their care through regular follow-ups in an outpatient setting. In addition to medical and nursing care, Sidra Medicine offers support services for patients and families, including social work, clinical nurse specialists, and case management. While formal support groups are under development, ongoing engagement with families is embedded throughout the care process.
Qatar Tribune
03-06-2025
- General
- Qatar Tribune
Sheikha Moza inaugurates new paediatric HSCT ward at Sidra Medicine
DOHA: Chairperson of Qatar Foundation for Education, Science and Community Development HH Sheikha Moza bint Nasser has officially inaugurated the new paediatric Hematopoietic Stem Cell Transplant (HSCT) ward at Sidra Medicine, a Qatar Foundation entity. The new ward is dedicated to treating children with blood disorders, immune system diseases, and genetic conditions. During the visit, Sheikha Moza toured the facility, engaged with clinical teams, and received an overview of the HSCT program's role in advancing care and stem cell and gene therapies for children in Qatar and the region. Her Highness was accompanied by Minister of Public Health HE Mansoor bin Ebrahim bin Saad Al Mahmoud, members of Sidra Medicine's Board of Directors and senior leadership, including Dr Iyabo Tinubu-Karch, Chief Executive Officer and Prof. Ibrahim Janahi, Chief Medical Officer. The HSCT ward is a core part of Sidra Medicine's HSCT Program, using curative therapies to provide life-saving care and treatment for children with a range of blood diseases and cancers. This includes malignant and non-malignant conditions such as leukemia, lymphoma, thalassemia, sickle cell disease, immune deficiencies, and metabolic disorders. HSCT also known as bone marrow transplant, replaces diseased or damaged bone marrow with healthy stem cells from the patient (autologous) or a donor (allogeneic). Dr Iyabo Tinubu-Karch, CEO of Sidra Medicine, said: "The opening of our new pediatric Hematopoietic Stem Cell Transplant Ward, the first of its kind in the country, marks a major step in expanding access to life-saving care for children in Qatar and the region. As the HSCT program grows, it will play a vital role in reducing the need for outbound referrals and in positioning Qatar as a center of excellence for pediatric cell and gene therapies. This is about building sustainable, high-quality care close to home for our patients and their families." Prof Ibrahim Janahi, Chief Medical Officer at Sidra Medicine, said: "The launch of the HSCT Ward reflects our commitment to supporting the Qatar National Vision 2030. It strengthens the foundation of a knowledge-based economy by building national expertise in precision and regenerative medicine. Our goal is to ensure that every child in Qatar can access the best possible treatment, close to home and grounded in clinical excellence." Managed by the Hematology and Oncology Division at Sidra Medicine, the new ward is designed exclusively for pediatric patients under the age of 18. It is divided into two main sections - one section for children undergoing HSCT and the other for patients with complex hematology-oncology diagnoses such as cancer, that require intensive chemotherapy and inpatient care. With an initial capacity of 20 beds, the new pediatric HSCT ward integrates cutting-edge infrastructure, including high-level isolation facilities that meet international infection control standards. It is scheduled to receive patients for autologous transplants in late June of 2025 with preparations underway to care for inpatient children who will undergo allogeneic transplants, at a later stage. Dr Ayman Saleh, Division Chief of Pediatric Hematology-Oncology & Hematopoietic Stem Cell Transplant at Sidra Medicine said: "Our HSCT program brings together key specialties to deliver advanced and curative care for children with complex conditions. With four autologous procedures successfully completed and plans underway to offer allogeneic transplants in the near future, we are building a strong foundation for pediatric cellular therapy in Qatar. This service is a testament to the pioneering and family-centered care and cure approach that we offer to all our patients." In addition to treating patients with various blood diseases and cancers, the HSCT program at Sidra Medicine is the core part of its precision medicine strategy to facilitate genomic research programs for pediatric autoimmune disorders, genetic and rare diseases. Sidra Medicine's HSCT program is further enhanced by a Good Manufacturing Practice (GMP)-qualified laboratory team operating under the Advanced Cell Therapy Core (ACTC). The ACTC manages the processing and cryopreservation of hematopoietic stem cells and is currently working toward Sidra Medicine's qualification as a treatment center for Casgevy, a gene therapy for thalassemia and sickle cell disease.
